1. Clinical outcomes following stereotactic body radiation therapy (SBRT) for non-resectable pancreatic adenocarcinoma
   Raj Singh et al, 2017, J Radiat Oncol CrossRef
2. Management of pancreatic cancer in the elderly.
   Oliver Higuera et al, 2016, World J Gastroenterol CrossRef
3. Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review
   William Paul Skelton et al, 2017, J Gastrointest Canc CrossRef
4. Current and future biomarkers for pancreatic adenocarcinoma
   Sven H Loosen et al, 2017, Tumour Biol. CrossRef
5. Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States
   Sunnie Kim et al, 2018, Adv Ther CrossRef
6. Chemotherapy in elderly patients with pancreatic cancer: efficacy, feasibility and future perspectives
   Marina Macchini et al, 2018, Cancer Treatment Reviews CrossRef
7. Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
   Ana Fernández et al, 2018, BMC Cancer CrossRef
8. Age‐related morphological changes in the pancreas and their association with pancreatic carcinogenesis
   Yoko Matsuda, 2019, Pathology International CrossRef
9. Impact of celiac neurolysis on survival in patients with pancreatic cancer
   Larissa L. Fujii-Lau et al, 2015, Gastrointestinal Endoscopy CrossRef
10. Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma
    Daneng Li et al, 2015, Clinical Colorectal Cancer CrossRef
11. Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience
    Namrata Vijayvergia et al, 2015, Journal of Geriatric Oncology CrossRef
12. Clinicopathological Features of 15 Occult and 178 Clinical Pancreatic Ductal Adenocarcinomas in 8339 Autopsied Elderly Patients
    Yoko Matsuda et al, 2016, Pancreas CrossRef
13. Prognostic and predictive markers in pancreatic adenocarcinoma
    Nha Le et al, 2016, Digestive and Liver Disease CrossRef
14. Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands
    N. Haj Mohammad et al, 2016, J Cancer Res Clin Oncol CrossRef
15. Update on the Management of Pancreatic Cancer in Older Adults
    Shin Yin Lee et al, 2016, Curr Oncol Rep CrossRef
16. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance
    Fuxin Jia et al, 2019, World J Surg Onc CrossRef
17. Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancer
    Amber Afzal et al, 2019, Thrombosis Research CrossRef
18. The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer
    Farshad Moradi et al, 2020, Seminars in Nuclear Medicine CrossRef
19. null
    Arvin Hajmirzaeian et al, 2021 CrossRef
20. Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy
    Sharavan Ramachandran et al, 2020, Molecular Therapy - Oncolytics CrossRef
21. The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registry
    L.J.H. Brada et al, 2020, Pancreatology CrossRef
22. The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
    Marwa Elsayed et al, 2021, Biomedicines CrossRef
23. Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach
    Jung Won Chun et al, 2021, BMC Cancer CrossRef
24. Performance status as prognostic factor in phase III trials of first‐line chemotherapy of unresectable or metastatic pancreatic cancer: A trial‐level meta‐analysis
    Giuseppe Colloca, 2021, Asia‐Pac J Clin Oncol CrossRef
25. Peripheral Blood Cell Variables Related to Systemic Inflammation in Patients With Unresectable or Metastatic Pancreatic Cancer
    Giuseppe Colloca et al, 2021, Pancreas CrossRef
26. Real‐world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma
    Kenneth H. Yu et al, 2021, Cancer Medicine CrossRef
27. Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling
    Pauline C. Xu et al, 2022, Sci Rep CrossRef
28. Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications
    Kiersten Preuss et al, 2022, Cancers CrossRef
29. Can Surgical Resection of Metastatic Lesions Be Beneficial to Pancreatic Ductal Adenocarcinoma Patients with Isolated Lung Metastasis?
    Won-Gun Yun et al, 2022, Cancers CrossRef
30. Pancreatic Ductal Cell-Derived Extracellular Vesicles Are Effective Drug Carriers to Enhance Paclitaxel’s Efficacy in Pancreatic Cancer Cells through Clathrin-Mediated Endocytosis
    Haoyao Sun et al, 2022, IJMS CrossRef
31. Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study
    Citadel J. Cabasag et al, 2022, Br J Cancer CrossRef
32. Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies
    Andreia S. Fernandes et al, 2022, Marine Drugs CrossRef
33. Association between Survival Duration of Older Patients with Advanced Unresectable Pancreatic Cancer and Appetite Loss: A Retrospective Cohort Study
    Ryuichi Ohta et al, 2022, Healthcare CrossRef
34. Pancreatic Cancer Resistance to Treatment: The Role of Microbiota
    Enrico Celestino Nista et al, 2023, Biomedicines CrossRef
35. Efficacy and Safety of Chemotherapy in Elderly Patients with Unresectable Pancreatic Cancer
    Byung Soo Kwan et al, 2023, JCM CrossRef
36. State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine
    Tommaso Schepis et al, 2023, Cancers CrossRef
37. A Rare Case of Abdominal Wall Skeletal Muscle Metastasis From Adenocarcinoma of the Pancreatic Head
    Brittney Shupp et al, 2023 CrossRef
38. Prognostic Indicators for Intracranial Metastases from Pancreatic Cancer: A Population-Based Retrospective Surveillance, Epidemiology, and End Results Database Analysis
    Liliana Ladner et al, 2023, World Neurosurgery CrossRef
39. Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
    Daniel J. Zabransky et al, 2024 CrossRef
40. Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments
    Doaa Bugazia et al, 2024, Front. Oncol. CrossRef
41. Metastatic Small Cell Lung Cancer Masquerading as a Pancreatic Mass: A Case Report
    Arjun R Gampala et al, 2024 CrossRef
42. Outcomes of phosphorus-32 microparticle intratumoral implantation added to chemotherapy in patients with metastatic pancreatic adenocarcinoma
    Amanda Huoy Wen Lim et al, 2024, iGIE CrossRef
43. Is Pancreatic Adenosquamous Carcinoma (PASC) a Surgical Disease? A Large Healthcare System Review
    Kyuseok Im et al, 2024, Surgical Oncology Insight CrossRef
44. Oncolytic Coxsackievirus B3 Strain PD-H Is Effective Against a Broad Spectrum of Pancreatic Cancer Cell Lines and Induces a Growth Delay in Pancreatic KPC Cell Tumors In Vivo
    Anja Geisler et al, 2024, IJMS CrossRef
45. Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma
    Yinyin Xue et al, 2024, Oncogene CrossRef